Skip to main content
Ulrike Buchwald, MD, Infectious Disease, Lutherville, MD

UlrikeKirstenBuchwaldMD

Infectious Disease • Lutherville, MD

HIV/AIDS Medicine, International Health, Travel & Tropical, Mycobacterial Disease, STD Medicine

Director, Clinical Vaccine Research, Merck & Co Clinical Assistant Professor, Medicine, University of Maryland School of Medicine

Join to view full profile

Dr. Buchwald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Buchwald's full profile

Already have an account?

  • Office

    Johns Hopkins Gastroenterology Green Spring Station
    2360 W Joppa Rd
    Lutherville, MD 21093
    Phone+1 410-933-7495

Education & Training

  • London School of Hygiene and Tropical Medicine
    London School of Hygiene and Tropical MedicineMS, Public Health, 2014 - 2019
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Infectious Disease, 2007 - 2010
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2004 - 2007
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1998

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2026
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • NJ State Medical License
    NJ State Medical License 2010 - 2011
  • NY State Medical License
    NY State Medical License 2009 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior Director
    Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior DirectorDecember 16th, 2023
  • CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase III
    CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase IIIFebruary 20th, 2024
  • Merck’s Capvaxive Wins FDA Approval as First Pneumonia Vaccine Designed for Adults
    Merck’s Capvaxive Wins FDA Approval as First Pneumonia Vaccine Designed for AdultsJune 22nd, 2024

Dr. Ulrike Buchwald, Dr. Ulrike Buchwald, MD, Dr. U Buchwald, Dr. Ulrike Kirsten Buchwald